James Patrick Nelli Jr. - 14 Feb 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
President
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Issuer symbol
HCAT
Transactions as of
14 Feb 2022
Net transactions value
+$150,000
Form type
4
Filing time
16 Feb 2022, 17:02:24 UTC
Previous filing
15 Dec 2021
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $21,536 +2,009 +1.4% $10.72 142,935 14 Feb 2022 Direct
transaction HCAT Common Stock Options Exercise $128,464 +12,051 +8.4% $10.66 154,986 14 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -2,009 -16% $0.000000 10,764 14 Feb 2022 Common Stock 2,009 $10.72 Direct F1
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -12,051 -100% $0.000000* 0 14 Feb 2022 Common Stock 12,051 $10.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the 12,773 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 26, 2021.
F2 25% of the 15,087 shares underlying the option vested in an annual installment and the remaining balance vested in equal monthly installments until the option vested in full on April 27, 2021.